ReviewInternational journal of molecular sciences2014
Survivin as a preferential target for cancer therapy.
Mahsa Mobahat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
90 papers cite itlatest 60 shown
this paperpooled itcites it